Biblio
Clofarabine for Lymphodepletion Before CAR-T-Cell Infusion: A Brief Case Report. J Pediatr Hematol Oncol. 2023.
. The Efficacy of Tacrolimus/Mycophenolate Mofetil as Acute Graft-Versus-Host-Disease Prophylaxis and the Impact of Sub Therapeutic Tacrolimus Levels in Children Following Matched Sibling Donor Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2014.
Exagamglogene Autotemcel for Severe Sickle Cell Disease. N Engl J Med. 2024.
Granulocyte Colony-Stimulating Factor is Safe and Well Tolerated following Allogeneic Transplantation in Patients with Sickle Cell Disease. Transplant Cell Ther. 2021.
Hematopoietic stem cell transplantation and cellular therapy in sickle cell disease: where are we now?. Curr Opin Hematol. 2019.
. Hematopoietic stem cell transplantation for CD40 ligand deficiency: results from an EBMT/ESID-IEWP-SCETIDE-PIDTC Study. J Allergy Clin Immunol. 2019.
Identification of unstable regulatory and autoreactive effector T cells that are expanded in patients with mutations. Sci Transl Med. 2023;15(727):eadg6822.
Improved Splenic Function After Hematopoietic Stem Cell Transplant for Sickle Cell Disease. Pediatr Blood Cancer. 2016.
. Length of Stay and Health Care Utilization Among Pediatric Autologous Hematopoietic Cell Transplantation Recipients. Transplant Cell Ther. 2021.
Limitations of Applying the Hematopoietic Cell Transplantation Comorbidity Index in Pediatric Patients Receiving Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2020.
. Metabolomic Identification of Alpha-Ketoglutaric Acid Elevation in Pediatric Chronic Graft-versus-Host Disease. Blood. 2021.
Outcomes of measurable residual disease in pediatric acute myeloid leukemia pre- and post-hematopoietic stem cell transplant: validation of difference from normal flow cytometry with chimerism studies and Wilms tumor 1 gene expression. Biol Blood Marrow Transplant. 2018.